Aryl Hydrocarbon Receptor and Autophagy-Related Protein Microtubule-Associated Protein Light Chain 3 Expression in

Jung Eun Kim1, Hye Ran Kim2, Seok Young Kang2

  • 1Department of Dermatology, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea.

Abstract

Insights

The aryl hydrocarbon receptor (AHR) and autophagy are implicated in psoriasis. AHR and autophagy may influence epidermal thickness and inflammation, suggesting therapeutic potential for skin diseases.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Cellular Biology

Background:

  • The aryl hydrocarbon receptor (AHR) and autophagy are crucial for skin homeostasis but also implicated in skin disorders.
  • Their specific roles in the pathogenesis of psoriasis remain largely unknown.

Purpose of the Study:

  • To investigate the immunohistochemical and gene expression of AHR, CYP1A1, and microtubule-associated protein light chain 3 (LC3) in psoriasis lesional skin.
  • To determine correlations between AHR, CYP1A1, and LC3 expression and clinicopathological features of psoriasis.

Main Methods:

  • Analysis of skin biopsies from 24 psoriasis patients and 10 healthy controls.
  • Immunohistochemistry, immunofluorescence, and western blotting for protein expression (AHR, CYP1A1, LC3).
  • Quantitative polymerase chain reaction for mRNA levels (AHR, CYP1A1, LC3, ATG5, BECN1, Nrf2).

Main Results:

  • Elevated AHR and CYP1A1 protein and mRNA expression in psoriasis lesions compared to controls.
  • Reduced LC3 protein and mRNA expression in psoriasis lesions.
  • Positive correlations between AHR/CYP1A1 and epidermal thickness/inflammatory cell density.
  • Negative correlations between LC3 and epidermal thickness/inflammatory cell density.
  • A significant inverse correlation between AHR and LC3 expression in psoriatic skin.

Conclusions:

  • AHR and autophagy signaling pathways are dysregulated in psoriasis.
  • These pathways may contribute to psoriasis pathogenesis by influencing epidermal hyperproliferation and inflammation.
  • Targeting AHR and autophagy presents a potential therapeutic strategy for chronic inflammatory skin diseases like psoriasis.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.9K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.4K